Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The dark side of tumor-associated endothelial cells
Francesco De Sanctis, Stefano Ugel, John G. Facciponte, et al.
Seminars in Immunology (2018) Vol. 35, pp. 35-47
Closed Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani‐Motlagh, Mehrnoush Ashja-Mahdavi, Angelica Loskog
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 603
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Mukaddes Izci, Christy Maksoudian, Bella B. Manshian, et al.
Chemical Reviews (2021) Vol. 121, Iss. 3, pp. 1746-1803
Open Access | Times Cited: 351
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 315
The emerging role of the piRNA/piwi complex in cancer
Yongmei Liu, Mei Dou, Xuxia Song, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 293
Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
Sonal Patel, Aftab Alam, Richa Pant, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 234
Monocytes in the Tumor Microenvironment
Stefano Ugel, Stefania Canè, Francesco De Sanctis, et al.
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 16, Iss. 1, pp. 93-122
Closed Access | Times Cited: 212
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
Yuxiao Song, Yang Fu, Qi Xie, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 203
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Diana Klein
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 173
Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment – New Findings and Future Perspectives
Laurenz Nagl, Lena Horvath, Andreas Pircher, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 148
Vascular Endothelial Cells: Heterogeneity and Targeting Approaches
Jan K. Hennigs, Christiane Matuszcak, Martin Trepel, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2712-2712
Open Access | Times Cited: 121
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Kevin Dzobo, Dimakatso Alice Senthebane, Collet Dandara
Cancers (2023) Vol. 15, Iss. 2, pp. 376-376
Open Access | Times Cited: 94
Medical gas plasma technology: Roadmap on cancer treatment and immunotherapy
Sander Bekeschus
Redox Biology (2023) Vol. 65, pp. 102798-102798
Open Access | Times Cited: 45
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
Mariantonietta D’Ambrosio, Jesús Gil
Developmental Cell (2023) Vol. 58, Iss. 12, pp. 1007-1021
Open Access | Times Cited: 44
Targeting endothelial permeability in the EPR effect
Behnaz Lahooti, Racheal G. Akwii, Fatema Tuz Zahra, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 212-235
Closed Access | Times Cited: 43
Endothelial cells in tumor microenvironment: insights and perspectives
Patrizia Leone, Eleonora Malerba, Nicola Susca, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 25
CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy
Monika C. Brunner‐Weinzierl, Christopher E. Rudd
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 132
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Shangwei Zhong, Ji-Hak Jeong, Zhikang Chen, et al.
Translational Oncology (2019) Vol. 13, Iss. 1, pp. 57-69
Open Access | Times Cited: 110
Cancer-Associated Angiogenesis: The Endothelial Cell as a Checkpoint for Immunological Patrolling
Antonio Giovanni Solimando, Simona De Summa, Angelo Vacca, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3380-3380
Open Access | Times Cited: 84
Vascular Microenvironment, Tumor Immunity and Immunotherapy
Zachary L Lamplugh, Yi Fan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 73
Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies
Hanxin Liu, Huifang Zhao, Yu Sun
Seminars in Cancer Biology (2021) Vol. 86, pp. 769-781
Open Access | Times Cited: 70
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer
Francesco De Sanctis, Silvia Dusi, Simone Caligola, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1378-1393.e14
Open Access | Times Cited: 10
The Engagement Between MDSCs and Metastases: Partners in Crime
Rosalinda Trovato, Stefania Canè, Varvara Petrova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 67
3D printed in vitro tumor tissue model of colorectal cancer
Haoxiang Chen, Yanxiang Cheng, Xiaocheng Wang, et al.
Theranostics (2020) Vol. 10, Iss. 26, pp. 12127-12143
Open Access | Times Cited: 67
Support of Tumor Endothelial Cells by Chemokine Receptors
Nicole Salazar, Brian A. Zabel
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top